Moderna Earnings: Maintaining Our $141 Fair Value ... - Morningstar

Moderna Earnings: Maintaining Our $141 Fair Value ... - Morningstar

2 weeks from now

Nov 7, 2024  · We’re maintaining our $141 fair value estimate for Moderna following strong third-quarter sales and a brief return to profitability, ahead of an expected dip in sales in the fourth quarter.

morningstar.com

Moderna: Fair Value Cut Following Lower 2025 Sales ... - Morningstar

2 weeks from now

Jan 14, 2025  · The bottom line: We lower our fair value estimate for no-moat Moderna to $102 per share from $141, after incorporating lower guidance for sales and additional cost-cutting. Even …

morningstar.com

Moderna: R&D Day Brings Dramatic Strategic Shift; Lowering Our …

2 weeks from now

Sep 13, 2024  · Moderna announced a strategic overhaul and new financial guidance at its R&D day on Sept. 12, and we’ve lowered our fair value estimate to $141 per share from $227.

morningstar.com

Moderna, Inc. (MRNA)

2 weeks from now

Morningstar • Stock Picks • 8 ... Moderna, Inc.: Moderna Earnings: Maintaining Our $141 Fair Value Estimate as Turnaround Looks on Track . Direction. Rating. Price Target. ... Moderna, …

yahoo.com

Moderna Earnings: Maintaining Our $227 Fair Value ... - Morningstar

2 weeks from now

May 2, 2024  · Morningstar is an investment research company offering mutual fund, ETF, and stock analysis, ratings, and data, and portfolio tools. Discover actionable insights today.

morningstar.com

Moderna Earnings: High-Level Long-Term Guidance Fits Our

2 weeks from now

Nov 3, 2023  · We’re maintaining our $227 fair value estimate after assessing the firm’s high-level guidance through 2025, which overall implies lower COVID revenue than we had anticipated, …

morningstar.com

Moderna, Inc. (MRNA) Stock Forecasts - Yahoo Finance

2 weeks from now

Nov 7, 2024  · Moderna, Inc.: Moderna Earnings: Maintaining Our $141 Fair Value Estimate as Turnaround Looks on Track

yahoo.com

Moderna Earnings: Maintaining $266 Fair Value Estimate As

2 weeks from now

Aug 8, 2023  · Moderna MRNA reported second-quarter results that were largely in line with our expectations, and we’re maintaining our $266 fair value estimate. The second quarter is an off …

morningstar.com

Eli Lilly Earnings: Raising Our Fair Value Estimate, But

2 weeks from now

2 days ago  · The bottom line: We're raising our Lilly fair value estimate to $620 from $580 to account for higher long-term growth from the oncology and immunology portfolio, which …

morningstar.com

Moderna, Inc. (MRNA) Stock Forecasts - Yahoo Finance

2 weeks from now

Aug 3, 2023  · Moderna, Inc.: Moderna Earnings: Maintaining $266 Fair Value Estimate as Broader Portfolio Catalysts Approach

yahoo.com

Moderna, Inc. (MRNA) Stock Price, News, Quote & History - Yahoo …

2 weeks from now

Morningstar • Analyst Report • 8 months ago Moderna, Inc.: Moderna Earnings: Maintaining Our $227 Fair Value Estimate as Pivotal-Stage Pipeline Grows Direction

yahoo.com

Victory Capital Reports Record Fourth-Quarter And Full

2 weeks from now

2 days ago  · Victory Capital Reports Record Fourth-Quarter and Full-Year Earnings Per Share. Fourth-Quarter Highlights. Total Client Assets of $176.1 billion Long-term gross flows of $6.6 …

morningstar.com

Narrow-Moat Lonza Benefits From Strong CDMO Outsourcing

2 weeks from now

Jan 30, 2025  · We raise our fair value estimate to CHF 550 from CHF 530 per share. We think Lonza is well-positioned to deliver strong long-term performance, particularly in the fast …

morningstar.com

Strategic Upward Striving Toward $100 Million Revenue: …

2 weeks from now

Bromiley 1991, Fiegenbaum et al. 1996). Last, our find-ings contribute to the growing research on multiple goals (Gaba and Joseph 2013, McCann and Vroom 2014, Gaba and Greve 2019, …

columbia.edu

Byrna Technologies Reports Record Results For Fiscal

2 weeks from now

1 day ago  · Results compare Q4 2024 to the 2023 fiscal fourth quarter ended November 30, 2023 unless otherwise indicated. Net revenue for Q4 2024 was $28.0 million, compared to $15.6 …

morningstar.com

Principal Financial Group Announces Full Year And Fourth

2 weeks from now

2 days ago  · Diluted earnings per common share. 2024. 4Q24 Net income attributable to PFG (in millions) 2024. 4Q24. Net income attributable to PFG $6.68 $3.92

morningstar.com

WEX Inc. Reports Fourth Quarter And Full Year 2024 ... - Morningstar

2 weeks from now

3 days ago  · WEX Inc. Reports Fourth Quarter and Full Year 2024 Financial Results. Q4 revenue decreased 4% year-over-year to $637 million; full year revenue increased 3% to $2.63 billion

morningstar.com